Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Novo Nordisk Is Falling. A Rival Weight-Loss Drug Is on the Way.
Novo Nordisk Is Falling. A Rival Weight-Loss Drug Is on the Way. · Barrons.com

In This Article:

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.